Jinlin Jiang

Jinlin Jiang is currently the Director at AstraZeneca, where they lead a team of ten scientists focused on process development for the CAR-T portfolio. They have previously held roles as an Associate Principal Scientist and Senior Scientist at AstraZeneca, leading upstream process development for both the COVID-19 vaccine and CAR-T cell therapies. Jinlin began their career as a Scientist at MedImmune and has an extensive educational background, holding a PhD in Chemical and Biomolecular Engineering from the University of Delaware and a Bachelor's degree in Biochemical Engineering from Zhejiang University.